DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
63	特発性血小板減少性紫斑病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02914054 (ClinicalTrials.gov)	October 1, 2016	19/9/2016	Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone	Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With 3 Cycles Pulses of High-dose Dexamethasone (HD-DXM)	ITP;Croticosteroid Therapy	Drug: High dose Dexamethasone pulses;Drug: Prednisone	Isfahan University of Medical Sciences	Adibvira	Completed	18 Years	N/A	All	36	Phase 2;Phase 3	Iran, Islamic Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

October 1, 2016

19/9/2016

Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone

Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With 3 Cycles Pulses of High-dose Dexamethasone (HD-DXM)

ITP;Croticosteroid Therapy

Drug: High dose Dexamethasone pulses;Drug: Prednisone

Isfahan University of Medical Sciences

Adibvira

Completed

18 Years

N/A

All

Phase 2;Phase 3

Iran, Islamic Republic of